FLUORESCITE

This brand name is authorized in Canada, Estonia, Hong Kong, Japan, New Zealand, Turkey, United States

Active ingredients

The drug FLUORESCITE contains one active pharmaceutical ingredient (API):

1 Fluorescein UNII 93X55PE38X - FLUORESCEIN SODIUM

Fluorescein is a fluorochrome used in medicine as a diagnostic stain. Fluorescein is used to make the blood vessels of the ocular fundus visible (angiography of the retina and choroid). Read about Fluorescein

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
FLUORESCITE Solution for injection	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
V04CX	Other diagnostic agents	V Various → V04 Diagnostic agents → V04C Other diagnostic agents
Discover more medicines within V04CX

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 00505005
Country: EE	Ravimiamet	Identifier(s): 1258141
Country: HK	Department of Health Drug Office	Identifier(s): 59383
Country: JP	医薬品医療機器総合機構	Identifier(s): 7290402A2035
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 6221
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699760751394, 8699760751400
Country: US	FDA, National Drug Code	Identifier(s): 0065-0092